Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.
Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] J M Rabey et. Al. Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa. Clinical Neuropharmacology, 23(6), 324-330 (2000).
[2] J P Finberg et. Al. Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor. Neuroreport, 9(4), 703-707 (1998).
[3] Orly Weinreb et. Al. Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice. Neurobiology of Aging, 36(9), 2628-2636 (2015).
分子式 C13H17NO3S |
分子量 267.34 |
CAS号 161735-79-1 |
储存方式 -20 ℃长期冷藏储存。冰袋运输 |
溶剂(常温) |
DMSO 53 mg/mL |
Water 53 mg/mL |
Ethanol 53 mg/mL |
体内溶解度
Saline 30 mg/mL
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们